- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/10 - Antimycotics
Patent holdings for IPC class A61P 31/10
Total number of patents in this class: 2776
10-year publication summary
81
|
90
|
152
|
202
|
195
|
233
|
183
|
220
|
365
|
117
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
King Faisal University | 912 |
206 |
Nihon Nohyaku Co., Ltd. | 327 |
26 |
Scynexis, Inc. | 68 |
23 |
POLA Pharma Inc. | 77 |
20 |
BASF SE | 20912 |
19 |
Centre National de La Recherche Scientifique | 10418 |
19 |
The Board of Trustees of the University of Illinois | 2689 |
19 |
Shanghai Techwell Biopharmaceutical Co., Ltd. | 67 |
17 |
Eisai R&D Management Co., Ltd. | 1237 |
15 |
F2g Ltd | 47 |
13 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2809 |
12 |
Kaken Pharmaceutical Co., Ltd. | 106 |
12 |
Janssen Pharmaceutica N.V. | 3392 |
10 |
Board of Regents, The University of Texas System | 5782 |
10 |
The Brigham and Women's Hospital, Inc. | 2181 |
10 |
University of Georgia Research Foundation, Inc. | 1021 |
10 |
Amtixbio Co., Ltd. | 38 |
10 |
The Regents of the University of California | 19887 |
9 |
President and Fellows of Harvard College | 5972 |
9 |
The Research Foundation for The State University of New York | 1615 |
9 |
Other owners | 2298 |